Live
ePaper
Search
Live ePaper

Copyright 2025 - All Right Reserved.
ITV Network Ltd 2025

Home > India > BRIEF-Knight Therapeutics – Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia

BRIEF-Knight Therapeutics – Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia

Written By:
Last Updated: October 6, 2026 17:19:24 IST

Follow us on
Google News

Share

Oct 6 (Reuters) – Knight Therapeutics Inc: * KNIGHT THERAPEUTICS – LAUNCHES TAVALISSE IN BRAZIL FOR CHRONIC IMMUNE THROMBOCYTOPENIA Source text: Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Russians open 220,000 digital rouble accounts in first month after launch, central bank says
BRIEF-Al Elm Renews Sharia-Compliant Banking Facilities Agreement
Sinner to miss rest of 2026 to recover from knee injury
Journalist groups urge X to reject broad account-blocking requests in Turkey
World shares advance as oil falls, bond yields retreat
AI hopes, industrial malaise drive boom in German startups
UPDATE 2-Spain approves housing decrees that triggered snap election
Sinner to miss rest of 2026 to recover from knee injury
BRIEF-Nextplat Completes Pensacola-Area Acquisition Of Profitable Pharmacy, Accelerating Continued Healthcare Growth And Profitability
AMD plans to substantially increase supply in 2027, CEO says

Follow Us

Facebook Twitter Youtube Instagram

India News : Find Latest India News and Breaking News from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and more.

मुख्य श्रेणियाँ

Follow Us

Facebook Twitter Youtube Instagram

India News : Find Latest India News and Breaking News from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and more.

मुख्य श्रेणियाँ

Group Websites

QUICK LINKS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?